FDA: Roche Test Flaws Could Misdiagnose Patients With COVID-19, Flu
Executive Summary
The US agency has contacted health care providers to warn them about faulty COBAS SARS-CoV-2 and Influenza A/B Nucleic Acid Tests for use on the COBAS Liat System.